Loading data for TYRA — first visit, this takes a few seconds.
Tyra Biosciences, Inc. (TYRA)
NasdaqGS: TYRA
· Real-Time Price · USD
24.94
-1.19 (-4.55%)
At close: Aug 31, 2026, 6:39 PM
The price, the headline numbers and the latest news, in one place.
Tyra Biosciences, Inc. (TYRA) Stock Price, Analysis & Data
No data available
| Bid | 25.18 |
| Market Cap | 1.49B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -149M |
| 0.77 | |
| -2.39 | |
| n/a | |
| -8.4 | |
| P/B (ttm) | 4.20 |
| P/S (ttm) | 0.00 |
| Earnings Date | Nov 4, 2026 |
| Ask | 32.25 |
| Volume | 217,472 |
| Avg. Volume (20D) | 789,482 |
| Open | 25.88 |
| Previous Close | 26.13 |
| Day's Range | 24.91 - 25.88 |
| 52-Week Range | 11.70 - 40.65 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TYRA
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clin...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 15, 2021
Employees 87
Stock Exchange NasdaqGS
Ticker Symbol TYRA
Website https://tyra.bio
Financial Performance
In 2025, Tyra Biosciences's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -119.95M, an increase of 38.7%.
Financial StatementsEarnings Surprise
Tyra Biosciences has released their quarterly earnings on Aug 4, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.69 misses estimates by -0.05, with -46.81% YoY decline.
Tyra Biosciences, Inc. is scheduled to release its earnings on Nov 4, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2